Journal
CANCER
Volume 127, Issue 22, Pages 4124-4130Publisher
WILEY
DOI: 10.1002/cncr.33854
Keywords
-
Categories
Ask authors/readers for more resources
A novel ARHGAP23-FER fusion was identified in a metastatic spindle-cell soft-tissue neoplasm, which exhibited a rapid and sustained metabolic response to the tyrosine kinase inhibitor lorlatinib.
A metastatic spindle-cell soft-tissue neoplasm was found to carry a novel ARHGAP23-FER fusion. The tumor showed a rapid and sustained metabolic response to tyrosine kinase inhibitor lorlatinib.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
